Resveratrol Research Overview (also known as 3,5,4'-trihydroxy-trans-stilbene, trans-resveratrol, E-resveratrol, trans-3,5,4'-trihydroxystilbene)
Resveratrol is a naturally occurring stilbene polyphenol found in the skins of red grapes, berries, peanuts, and several medicinal plants. It is investigated for effects on cellular stress responses, mitochondrial function, inflammation, vascular biology, glucose metabolism, and age-related disease, although human evidence remains mixed and does not establish resveratrol as a proven longevity treatment.
What Is Resveratrol?
Resveratrol is a nonflavonoid polyphenolic compound belonging to the stilbene family. It is produced by some plants as a phytoalexin, or antimicrobial defense molecule, in response to environmental stress. Dietary sources include the skin of red and purple grapes, red wine, blueberries, cranberries, peanuts, and certain traditional medicinal plants. Commercial research products generally contain trans-resveratrol, the more biologically studied geometric isomer, because the cis form is less stable and has been evaluated less extensively.
Resveratrol is studied in longevity and anti-aging research because it influences several pathways associated with cellular stress adaptation, metabolic regulation, vascular function, and inflammation. It has been investigated in cell cultures, laboratory animals, and human clinical studies involving cardiometabolic health, endothelial function, cognitive aging, insulin sensitivity, and inflammatory conditions. Results vary substantially according to formulation, dose, treatment duration, participant health, and the biological endpoint measured. Resveratrol should therefore be regarded as a research compound rather than a clinically established anti-aging intervention.
Research Indications
Metabolic Health
Insulin Sensitivity and Glucose Handling
Small human trials have examined resveratrol for effects on insulin sensitivity, glucose control, and related metabolic markers, with mixed results across populations and doses.
Mitochondrial and Energy Metabolism Markers
Short-term studies in adults with obesity have reported changes consistent with calorie-restriction-like metabolic signaling, though clinical relevance remains uncertain.
Cardiovascular and Vascular Function
Endothelial Function
Research has investigated nitric-oxide-related and flow-mediated dilation endpoints; findings are heterogeneous and do not establish cardiovascular disease prevention.
Blood Pressure and Lipids
Meta-analytic and individual-trial findings vary by dose, baseline health, and study duration. Resveratrol is not a substitute for prescribed cardiovascular treatment.
Cognitive Aging
Memory and Hippocampal Connectivity
A controlled trial in healthy older adults reported memory and hippocampal connectivity findings, but replication and longer clinical studies are needed.
Neuroinflammatory Pathways: Preclinical work supports biological plausibility, but meaningful prevention or treatment effects in neurodegenerative disease remain unproven in humans.
Longevity Signaling
Sirtuin-Related Signaling
Resveratrol is widely studied for interactions with stress-response and sirtuin-related pathways, although direct translation of these mechanisms to human longevity is unresolved.
Healthspan Outcomes
There is no persuasive human evidence that supplementation extends lifespan. Long-term healthspan outcomes have not been established.
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| General low-dose research | 100–150 mg | Once daily | Oral |
| Metabolic marker studies | 150–500 mg | Once daily | Oral |
| Cognitive-aging trial designs | 200 mg | Once daily | Oral |
| High-dose short-term studies | 1,000–2,000 mg | Once daily or divided | Oral |
Timing
Human studies commonly administer resveratrol with a meal, often in the morning. Taking it with food may improve gastrointestinal tolerability; consistency in timing is more important than a specific hour. High-dose protocols warrant clinician oversight because interaction and adverse-effect risk may increase.
Peptide Interactions
Resveratrol may affect platelet activity and drug-metabolizing enzymes. Concurrent anticoagulant or antiplatelet therapy should be reviewed by a clinician.
Potential additive effects on bleeding tendency are a concern, particularly at higher supplemental doses or when several blood-thinning agents are combined.
Both are studied for metabolic effects. Additive glucose-lowering effects are possible; monitor for symptoms of low blood glucose if used with glucose-lowering medication.
In vitro and limited clinical evidence suggest potential effects on several metabolic enzymes. Relevance depends on dose and the medication’s therapeutic window.
Resveratrol has phytoestrogenic activity in experimental systems. People with hormone-sensitive cancer or conditions should obtain specialist guidance before supplemental use.
No well-established clinically important interaction is known at typical dietary or supplemental intakes, although individual gastrointestinal tolerance may differ.
Reported Research Timeline
01First dose to 3 days (reported in cited studies): most people notice no acute effect. Gastrointestinal upset, nausea, loose stool, or headache can occur, especially with larger doses.
02Week 1–2 (reported in cited studies): tolerability is the principal observable outcome. There is no reliable short-term subjective marker that confirms metabolic or longevity-related activity.
03Weeks 3–4 (reported in cited studies): research protocols may assess fasting glucose, insulin, blood pressure, or inflammatory markers, but individual changes are variable and often small.
04Weeks 8–12 (reported in cited studies): this is a common duration for controlled supplementation studies. Any laboratory changes should be interpreted with baseline values, diet, exercise, and medication use in mind.
05Beyond 3 months: evidence for sustained benefit and long-term safety at high supplemental doses is limited. Periodic reassessment with a healthcare professional is appropriate for ongoing use.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
Oral resveratrol is generally studied as a short-term supplement; higher doses are more likely to cause gastrointestinal symptoms.
Discuss use before starting if taking anticoagulant, antiplatelet, antidiabetic, or prescription medicines with narrow therapeutic ranges.
Avoid nonessential supplementation during pregnancy or breastfeeding because adequate safety data are lacking.
Stop supplemental use before elective surgery only under the direction of the surgical team; disclose all supplements during pre-operative review.
People with hormone-sensitive conditions should seek clinician guidance because resveratrol has estrogenic and anti-estrogenic activity in experimental models.
Seek Medical Attention If:
Signs of an allergic reaction occur, including facial swelling, hives, wheezing, or difficulty breathing.
Unusual bleeding, black stools, vomiting blood, or persistent unexplained bruising develops.
Severe or persistent abdominal pain, vomiting, or diarrhea prevents normal hydration or food intake.
Symptoms of low blood glucose occur while using diabetes medication, such as confusion, sweating, shakiness, or fainting.
Quality Indicators
Verified Marker
Batch-Specific Certificate of Analysis
Look for a lot-matched COA identifying trans-resveratrol content, test date, laboratory identity, and analytical method.
Verified Marker
Third-Party Identity and Purity Testing
Prefer products independently tested using HPLC or equivalent methods for identity and stated trans-resveratrol purity.
Verified Marker
Contaminant Screening
A credible panel should include heavy metals and microbiological testing, particularly for botanical-source raw materials.
Acceptable Range
Clear Capsule and Dose Disclosure
The label should distinguish trans-resveratrol from whole polygonum or grape extract and state the milligrams per capsule and serving.
Quality Concern
Proprietary Blends or Unverifiable Purity Claims
Avoid products that hide individual ingredient quantities, provide only generic testing claims, or do not make a current lot-specific COA available.
Research Citations
- Resveratrol improves health and survival of mice on a high-calorie diet.
Baur, J.A., Pearson, K.J., et al., 2006, Nature - Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.
Timmers, S., Konings, E., et al., 2011, Cell Metabolism - Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.
Witte, A.V., Kerti, L., et al., 2014, Journal of Neuroscience - High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled, double blind cross-over trial.
Poulsen, M.M., Vestergaard, P.F., et al., 2013, Diabetes
Research Focus
longevity, healthy aging, cardioprotection, endothelial function, mitochondrial biology, inflammation, glucose metabolism, sirtuin signaling, oxidative stress
Frequently Asked Questions
What should researchers watch for with Resveratrol?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with Resveratrol?
First dose to 3 days (reported in cited studies): most people notice no acute effect. Gastrointestinal upset, nausea, loose stool, or headache can occur, especially with larger doses.
How is Resveratrol typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →